200
Participants
Start Date
June 30, 2011
Primary Completion Date
June 30, 2016
Study Completion Date
June 30, 2017
Placebo
two tablets in the morning and two in the evening.
Sorafenib
400 mg Sorafenib bid until PD if staging after Run-In was PR or CR
Sorafenib
400 mg Sorafenib bid until PD if staging after Run-In was SD
Universitätsmedizin Berlin, Charité Campus Benjamin Franklin, Berlin
Univesitätsklinikum Essen, Essen
Universitätsklinikum Erlangen, Erlangen
Collaborators (1)
ClinAssess GmbH
INDUSTRY
Prof. Dr. med. Max. E. Scheulen
OTHER